Hims & Hers director gets 778 RSUs for fees

Hims & Hers Health, Inc. (HIMS) director David B. Wells reported equity compensation activity involving 778 Restricted Stock Units (RSUs) on August 14, 2026.

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) director David B. Wells reported equity compensation activity involving 778 Restricted Stock Units (RSUs) on August 14, 2026. Each RSU represents a contingent right to receive one share of Class A Common Stock, granted under the company’s Director Compensation Policy in lieu of a cash retainer. The filing notes that the RSUs, calculated from $23,760 of foregone cash fees at a $30.40 grant price, will vest in full on the company’s next quarterly vesting date. Following the reported transactions, Wells is shown with 229,808 shares of Class A Common Stock held directly.

Insider Trade Summary

778 shares exercised/converted

Exercise 2 txns

Insider WELLS DAVID B

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit F1, F2	778	$0.00	$0.00
Exercise	Class A Common Stock F1	778	--	--

Holdings After Transaction: Restricted Stock Unit — 0 contracts (Direct); Class A Common Stock — 229,808 shares (Direct)

Footnotes (2)

1. F1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. F2. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Key Figures

RSUs granted: 778 RSUs Foregone cash fees: $23,760 Grant price: $30.40 +2 more

5 metrics

RSUs granted 778 RSUs Restricted Stock Units representing a contingent right to one Class A share each

Foregone cash fees $23,760 Director retainer fee for the second quarter of 2026 exchanged for RSUs

Grant price $30.40 Used to convert foregone cash fees into number of RSUs granted

Shares underlying RSUs 778 shares Each RSU corresponds to one share of Class A Common Stock

Direct Class A holdings after transaction 229,808 shares Directly held by David B. Wells following the reported Form 4 transactions

Key Terms

Restricted Stock Units ("RSUs"), Director Compensation Policy, director retainer fee, grant price

4 terms

Restricted Stock Units ("RSUs") financial

"The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Director Compensation Policy financial

"The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy"

director retainer fee financial

"in lieu of the director retainer fee for the second quarter of 2026"

grant price financial

"The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did HIMS director David B. Wells report in this Form 4?

David B. Wells reported a grant of 778 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Hims & Hers Class A Common Stock as director compensation.

How was the HIMS RSU grant to David B. Wells for Q2 2026 calculated?

The RSU grant was based on foregone cash director fees of $23,760, divided by a grant price of $30.40 per share, resulting in 778 RSUs issued under the Director Compensation Policy.

When will David B. Wells’s HIMS RSUs vest?

The filing states that the 778 RSUs granted to David B. Wells will vest in full on the company’s next quarterly vesting date, aligning with Hims & Hers’ director compensation schedule.

How many HIMS Class A shares does David B. Wells hold after the reported transactions?

After the reported transactions, David B. Wells is shown as directly holding 229,808 shares of Hims & Hers Class A Common Stock, according to the Form 4 data.

Was the HIMS RSU activity for David B. Wells a market purchase or sale?

No market purchases or sales were reported. The Form 4 reflects equity compensation via RSUs granted in lieu of cash fees, with derivative exercise/conversion mechanics, not open-market trading.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 05:04 PM EDT Accepted by SEC EDGAR 08/18/2026 - 05:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WELLS DAVID B

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/14/2026		M		778	A	(1)	229,808	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/14/2026		M			778	(2)	(2)	Class A Common Stock	778	$0	0	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $23,760 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for David B Wells	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)